Cargando…

Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids

INTRODUCTION: Gabapentin and pregabalin (gabapentinoids) can be given with opioids for opioid-sparing and adjuvant analgesic effects. In the context of certain comorbidities and high dosages, coadministration of these agents can lead to respiratory depression or oversedation, necessitating naloxone...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desai, Payal H., Taylor, Olesya, Shah, Kunal J., Evoy, Kirk E., Peckham, Alyssa M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	College of Psychiatric & Neurologic Pharmacists 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287869/ https://www.ncbi.nlm.nih.gov/pubmed/34316417 http://dx.doi.org/10.9740/mhc.2021.07.225

Ejemplares similares

Letter to the Editor: Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”
por: Peckham, Alyssa M., et al.
Publicado: (2021)

Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
por: Martin, Yvette N., et al.
Publicado: (2019)

Risk of respiratory depression with opioids and concomitant gabapentinoids
por: Savelloni, Julie, et al.
Publicado: (2017)

Risk of respiratory depression with opioids and concomitant gabapentinoids [Corrigendum]
Publicado: (2018)

Opioid and gabapentinoid prescriptions in England from 2015 to 2020
por: Xia, Yixue, et al.
Publicado: (2022)

Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

High opioid doses, naloxone, and central nervous system active medications received by Medicare‐enrolled adults
por: Silva Almodóvar, Armando, et al.
Publicado: (2022)

Quality of Life and Healthcare Resource in Patients Receiving Opioids for Chronic Pain: A Review of the Place of Oxycodone/Naloxone
por: Morlion, Bart, et al.
Publicado: (2014)

Trends in the Use of Gabapentinoids and Opioids in the Postoperative Period Among Older Adults
por: Bongiovanni, Tasce, et al.
Publicado: (2023)

No Pharmacokinetic Interactions Between Elbasvir or Grazoprevir and Buprenorphine/Naloxone in Healthy Participants and Participants Receiving Stable Opioid Agonist Therapy
por: Feng, Hwa‐Ping, et al.
Publicado: (2018)

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
por: Bharat, Chrianna, et al.
Publicado: (2022)

Considering the Potential Benefits of Over-the-Counter Naloxone
por: Evoy, Kirk E, et al.
Publicado: (2021)

Association of Gabapentinoids With the Risk of Opioid-Related Adverse Events in Surgical Patients in the United States
por: Bykov, Katsiaryna, et al.
Publicado: (2020)

The risk of hemorrhagic complications in hospital in-patients who fall while receiving antithrombotic therapy
por: Bond, Andrew J, et al.
Publicado: (2005)

Practical implications of naloxone knowledge among suburban people who use opioids
por: Schneider, Kristin E., et al.
Publicado: (2021)

Fatalities associated with gabapentinoids in England (2004–2020)
por: Kalk, Nicola J., et al.
Publicado: (2022)

Naloxone for opioid toxicity and overdose in the community
por: Jauncey, Marianne, et al.
Publicado: (2021)

Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: Observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records
por: Macleod, John, et al.
Publicado: (2019)

Biphasic Effects of Naloxone in the Rats Receiving Morphine Overdose A Place Preference Study
por: Karimi, Sara, et al.
Publicado: (2011)

A study of the reasons for prescribing and misuse of gabapentinoids in prison including their co-prescription with opioids and antidepressants
por: Soni, Anju, et al.
Publicado: (2021)

Overuse of the psychoactive analgesics’ opioids and gabapentinoid drugs in patients having surgery for nerve entrapment disorders
por: Dahlin, Lars B., et al.
Publicado: (2023)

Current Evidence on Abuse and Misuse of Gabapentinoids
por: Hägg, Staffan, et al.
Publicado: (2020)

Characterizing opioid use disorder patients who have received medication trials with both buprenorphine and methadone
por: Wilder, Christine M, et al.
Publicado: (2015)

Geographic Variation in the Use of Gabapentinoids and Opioids for Pain in a Commercially Insured Adult Population in the United States
por: Zhao, Danni, et al.
Publicado: (2022)

621 Ethical Considerations to Prevent Burns in Patients Who Smoke While Receiving Home Oxygen Therapy
por: Khoo, Kimberly H, et al.
Publicado: (2022)

Post-operative opioid pain management patterns for patients who receive hip surgery
por: Cook, Chad E., et al.
Publicado: (2017)

Rate of opioid use disorder in adults who received prescription opioid pain therapy—A secondary data analysis
por: Just, Johannes M., et al.
Publicado: (2020)

Gabapentinoids: Gabapentin and Pregabalin for Postoperative Pain Management
por: Imani, Farnad, et al.
Publicado: (2012)

A snapshot on the usage pattern of gabapentinoids in Oman
por: Badi, Abdulaziz Said Al, et al.
Publicado: (2022)

Receipt of Substance Use Counseling Among Ambulatory Patients Prescribed Opioids in the United States
por: Evoy, Kirk E, et al.
Publicado: (2020)

Risk of major adverse events associated with gabapentinoid and opioid combination therapy: A systematic review and meta-analysis
por: Hahn, Jongsung, et al.
Publicado: (2022)

Reasons People Who Use Opioids Do Not Accept or Carry No-Cost Naloxone: Qualitative Interview Study
por: Bennett, Alex S, et al.
Publicado: (2020)

Correction: Rate of opioid use disorder in adults who received prescription opioid pain therapy—A secondary data analysis
por: Just, Johannes M., et al.
Publicado: (2021)

Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab
por: Choi, Sujin, et al.
Publicado: (2021)

Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
por: McAnally, Heath, et al.
Publicado: (2020)

Gabapentinoids for Pruritus in Older Adults: A Narrative Review
por: Sreekantaswamy, Shreya A., et al.
Publicado: (2021)

Reply to Letter to the Editor Regarding Article: “Considering the Potential Benefits of Over-The-Counter Naloxone” [Response To Letter]
por: Evoy, Kirk E, et al.
Publicado: (2021)

Overdose Prevention and Naloxone Prescription for Opioid Users in San Francisco
por: Enteen, Lauren, et al.
Publicado: (2010)

Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
por: Mauger, Sofie, et al.
Publicado: (2014)

Opioid Education and Nasal Naloxone Rescue Kits in the Emergency Department
por: Dwyer, Kristin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rb0liohbc51csc3iak0899i926